Hence, more studies investigating cortical effects of different subtypes of GLP-1 on depression or anxiety at the whole brain level, with longer assessment periods, and complete neuropsychological evaluations or behavioral observations are still needed both for preclinical and clinical studies. This evidence concerns the gene GLP1R and depressive symptom measurement.